PerspectiveCancer Immunotherapy

Clinical implications of tumor-intrinsic mechanisms regulating PD-L1

See allHide authors and affiliations

Science Translational Medicine  06 Feb 2019:
Vol. 11, Issue 478, eaav4810
DOI: 10.1126/scitranslmed.aav4810

Article Information

vol. 11 no. 478

PubMed: 
Print ISSN: 
Online ISSN: 
History: 
  • Received for publication September 20, 2018
  • Accepted for publication January 4, 2019
  • .

Author Information

  1. Alessandro Prestipino1,2 and
  2. Robert Zeiser1,*
  1. 1Department of Hematology and Oncology, Freiburg University Medical Center, 79106 Freiburg, Germany.
  2. 2Faculty of Biology, Albert Ludwigs University of Freiburg, 79104 Freiburg, Germany.
  1. *Corresponding author. Email: robert.zeiser{at}uniklinik-freiburg.de

Altmetric

Article usage

Article usage: February 2019 to July 2020

AbstractFullPdf
Feb 201941511001675
Mar 2019384101111
Apr 20192529571
May 20192138338
Jun 2019898315108
Jul 201920810862
Aug 201950210287
Sep 20191375024
Oct 20191194638
Nov 20191164936
Dec 20191123224
Jan 20201133429
Feb 2020852520
Mar 20201326244
Apr 20201124845
May 20201322632
Jun 20201043019
Jul 20202278

Stay Connected to Science Translational Medicine